Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors.
Development of multiple complications in type 2 diabetes is associated with the increase of multiple markers of chronic inflammation.
Evaluation of available risk scores to predict multiple cardiovascular complications for patients with type 2 diabetes mellitus using electronic health records.
Type 2 Diabetes Mellitus and Cognitive Impairment.
Damanik J, Yunir E.
Acta Med Indones. 2021 Apr;53(2):213-220.
Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention.
Wu Y, Ding Y, Tanaka Y, Zhang W.
Int J Med Sci. 2014 Sep 6;11(11):1185-200. doi: 10.7150/ijms.10001. eCollection 2014.
Pathophysiology of Type 2 Diabetes in Children and Adolescents.
Valaiyapathi B, Gower B, Ashraf AP.
Curr Diabetes Rev. 2020;16(3):220-229. doi: 10.2174/1573399814666180608074510.
[Exercise and oxidative stress in type 2 diabetes mellitus].
Poblete-Aro C, Russell-Guzmán J, Parra P, Soto-Muñoz M, Villegas-González B, Cofré-Bolados C, Herrera-Valenzuela T.
Rev Med Chil. 2018 Mar;146(3):362-372. doi: 10.4067/s0034-98872018000300362.
Type 2 diabetes mellitus in older adults: clinical considerations and management.
Bellary S, Kyrou I, Brown JE, Bailey CJ.
Nat Rev Endocrinol. 2021 Sep;17(9):534-548. doi: 10.1038/s41574-021-00512-2. Epub 2021 Jun 25.
Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention.
Wong ND, Sattar N.
Nat Rev Cardiol. 2023 Oct;20(10):685-695. doi: 10.1038/s41569-023-00877-z. Epub 2023 May 16.
Alterations in the gut virome are associated with type 2 diabetes and diabetic nephropathy.
Fan G, Cao F, Kuang T, Yi H, Zhao C, Wang L, Peng J, Zhuang Z, Xu T, Luo Y, Xie Y, Li H, Zhang K, Zeng Y, Zhang X, Peng S, Qiu X, Zhou D, Liang H, Yang B, Kang J, Liu Y, Zhang Y.
Gut Microbes. 2023 Jan-Dec;15(1):2226925. doi: 10.1080/19490976.2023.2226925.
Biomarkers in Diabetic Retinopathy.
Jenkins AJ, Joglekar MV, Hardikar AA, Keech AC, O'Neal DN, Januszewski AS.
Rev Diabet Stud. 2015 Spring-Summer;12(1-2):159-95. doi: 10.1900/RDS.2015.12.159. Epub 2015 Aug 10.
Cardiac Autonomic Neuropathy in Diabetes Mellitus.
Agashe S, Petak S.
Methodist Debakey Cardiovasc J. 2018 Oct-Dec;14(4):251-256. doi: 10.14797/mdcj-14-4-251.
Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications, and attenuates inflammation in type 2 diabetic rats.
Yu S, Cheng Y, Zhang L, Yin Y, Xue J, Li B, Gong Z, Gao J, Mu Y.
Stem Cell Res Ther. 2019 Nov 20;10(1):333. doi: 10.1186/s13287-019-1474-8.
